Related Experiment Video
Updated: Jul 18, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Predicting the molecular mechanism-driven progression of breast cancer through comprehensive network pharmacology and
Bharti Vyas1, Sunil Kumar2, Ratul Bhowmik3
1School of Interdisciplinary Science and Technology, Jamia Hamdard, New Delhi, India.
Abstract:
Identification of key regulators is a critical step toward discovering biomarker that participate in BC. A gene expression dataset of breast cancer patients was used to construct a network identifying key regulators in breast cancer. Overexpressed genes were identified with BioXpress, and then curated genes were used to construct the BC interactome network. As a result of selecting the genes with the highest degree from the BC network and tracing them, three of them were identified as novel key regulators, since they were involved at all network levels, thus serving as the backbone. There is some evidence in the literature that these genes are associated with BC. In order to treat BC, drugs that can simultaneously interact with multiple targets are promising. When compared with single-target drugs, multi-target drugs have higher efficacy, improved safety profile, and are easier to administer. The haplotype and LD studies of the FN1 gene revealed that the identified variations rs6707530 and rs1250248 may both cause TB, and endometriosis respectively. Interethnic differences in SNP and haplotype frequencies might explain the unpredictability in association studies and may contribute to predicting the pharmacokinetics and pharmacodynamics of drugs using FN1.
Insights
Researchers identified three novel key regulators in breast cancer (BC) by analyzing gene expression data and constructing a BC interactome network. These regulators are crucial for understanding BC biomarkers and developing multi-target drugs.
Area of Science:
- Genomics
- Bioinformatics
- Cancer Biology
Background:
- Identifying key regulators is crucial for discovering breast cancer (BC) biomarkers.
- Understanding gene networks can reveal novel therapeutic targets.
- Multi-target drugs show promise for BC treatment due to higher efficacy and improved safety.
Purpose of the Study:
- To identify novel key regulators in breast cancer using gene expression data.
- To construct a breast cancer interactome network to understand regulatory mechanisms.
- To explore the potential of identified regulators as targets for multi-target drug development.
Main Methods:
- Utilized a gene expression dataset from breast cancer patients.
- Employed BioXpress to identify overexpressed genes.
- Constructed a breast cancer interactome network and analyzed gene degrees to find key regulators.
Main Results:
- Identified three novel key regulators central to the breast cancer network.
- These regulators were involved at all network levels, forming the network's backbone.
- Found evidence linking these genes to breast cancer in existing literature.
Conclusions:
- The identified key regulators are critical for breast cancer progression and hold potential as biomarkers.
- These novel regulators could serve as targets for developing effective multi-target drugs for breast cancer.
- Further research into FN1 gene variations (rs6707530, rs1250248) may aid in predicting drug pharmacokinetics and pharmacodynamics.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...